| Company/Division name | AmbioPharm |
| Parent company | AmbioPharm |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 202 |
| Year reshoring announced: | 2026 |
| Year reshoring implemented or to be implemented: | 2027 |
| Capital investment ($): | 119 |
| City reshored to: | North Augusta |
| State(s) reshored to: | SC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | peptides |
| What domestic positive factors made reshoring more attractive? | Infrastructure, Manufacturing/engineering joint innovation (R&D), Skilled workforce availability/training |
